IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells

Shiwen Xu,Chunyan Yu,Xiaoxia Ma,Yan Li,Yangyang Shen,Yan Chen,Suhui Huang,Tongshuo Zhang,Weimin Deng,Yue Wang
DOI: https://doi.org/10.1016/j.ejphar.2020.173817
IF: 5.195
2021-03-01
European Journal of Pharmacology
Abstract:<p>The inflammatory milieu in tumor modulates the resistance to the conventional antitumoral therapies. Interleukin-6 (IL-6), a pleiotropic pro-inflammatory cytokine and a crucial mediator of tumor development, has been targeted as a therapeutic strategy to overcome chemoresistance in the treatment of tumors. The protein levels and nuclear translocation of HIFs (hypoxia-inducible factors), such as HIF-1α, are linked to the drug resistance of tumor cells. However, whether IL-6 promotes the nuclear translocation of HIF-1α and the related mechanism remain to be investigated. We applied two ovarian cancer (OvCa) cell lines, A2780 cells and SKOV3 cells for the in vivo and in vitro studies. We found that IL-6 up-regulates the HIF-1α expression via the signal transducer and activator of transcription 3 (STAT3) signaling under hypoxia in either endogenous or exogenous way, and then we proved that IL-6 enhances the transcriptional activity of HIF-1α via the STAT3 signaling. Further mechanism research revealed that IL-6 promotes the nuclear translocation of HIF-1α through the STAT3 signaling under hypoxia. Proliferation assay and apoptosis assay were applied and proved that IL-6 enhances the chemoresistance of OvCa cells against cisplatin through the upregulation of HIF-1α via the STAT3 signaling in vitro. The In vivo studies confirmed the effect of IL-6 in increasing the chemoresistance of OvCa cells against cisplatin through the IL-6/STAT3/HIF-1α loop in the animal models. Our data elucidates the explicit mechanism of IL-6/STAT3/HIF-1α loop in OvCa and also provides new insights into the development of different approaches for the inflammation-induced and hypoxia-induced resistance in tumor therapies.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: How does interleukin - 6 (IL - 6) promote the nuclear translocation of hypoxia - inducible factor - 1α (HIF - 1α) through the signal transducer and activator of transcription 3 (STAT3) signaling pathway, thereby exacerbating the resistance of ovarian cancer cells to the chemotherapeutic drug cisplatin? Specifically, the study explored the mechanism by which IL - 6 up - regulates the expression of HIF - 1α through the STAT3 signaling pathway under hypoxic conditions and promotes its nuclear translocation, and how this process affects the proliferation and apoptosis of ovarian cancer cells, thereby enhancing their resistance to cisplatin. ### Research Background - **Ovarian Cancer**: Ovarian cancer is one of the most deadly gynecological cancers with a high mortality rate. - **The Role of IL - 6**: IL - 6 is a pleiotropic pro - inflammatory cytokine and plays an important role in the progression and prognosis of ovarian cancer. The inflammatory response in the tumor microenvironment can affect the resistance to traditional anti - tumor therapies. - **HIF - 1α and Resistance**: HIF - 1α is associated with tumor progression and metastasis in various solid tumors, and its increased expression is related to chemoresistance. Under hypoxic conditions, the stabilization and nuclear translocation of HIF - 1α can induce the expression of multiple target genes, which are directly or indirectly involved in chemoresistance. ### Research Objectives - **Mechanism Research**: Explore the specific mechanism by which IL - 6 promotes the nuclear translocation of HIF - 1α through the STAT3 signaling pathway. - **Function Verification**: Verify that IL - 6 enhances the resistance of ovarian cancer cells to cisplatin by up - regulating the expression of HIF - 1α and its nuclear translocation. ### Main Findings 1. **The Role of Exogenous IL - 6**: - Exogenous IL - 6 up - regulates the expression of HIF - 1α through the STAT3 signaling pathway under hypoxic conditions. - IL - 6 treatment significantly increases the nuclear translocation of HIF - 1α. 2. **The Role of Endogenous IL - 6**: - Endogenous IL - 6 also up - regulates the expression of HIF - 1α through the STAT3 signaling pathway under hypoxic conditions. - In the cell line over - expressing IL - 6 (A2780/ssIL - 6), the nuclear translocation of HIF - 1α under hypoxic conditions is significantly increased, while in the cell line with inhibited IL - 6 expression (SKOV3/asIL - 6), the opposite is true. 3. **The Transcriptional Activity of HIF - 1α**: - IL - 6 enhances the transcriptional activity of HIF - 1α by activating the STAT3 signaling pathway. 4. **Chemoresistance**: - IL - 6 enhances the resistance of ovarian cancer cells to cisplatin by up - regulating the expression of HIF - 1α and its nuclear translocation. - Inhibiting the STAT3 signaling pathway or HIF - 1α can reverse the resistance caused by IL - 6. ### Conclusion This study reveals the mechanism by which IL - 6 promotes the nuclear translocation of HIF - 1α through the STAT3 signaling pathway, thereby exacerbating the resistance of ovarian cancer cells to cisplatin. This finding provides new ideas for the development of new treatment methods for inflammation - and hypoxia - induced resistance.